BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Baxter International, Inc. 

One Baxter Parkway

Deerfield  Illinois  60015  U.S.A.
Phone: 847-948-2000 Fax: 847-948-3642


SEARCH JOBS




Baxter International, Inc. (NYSE:BAX) is a global healthcare company that, through its subsidiaries assists healthcare professionals and their patients with treatment of complex medical conditions including hemophilia, immune disorders, kidney disease, cancer, trauma and other conditions. With 2006 sales of $10.4 billion, and approximately 45,000 employees, Baxter applies its expertise in medical devices, pharmaceuticals and biotechnology to make a meaningful difference in patients' lives.

Business Overview:

BioScience
Baxter is a leading manufacturer of plasma-based and recombinant proteins used to treat hemophilia. Other biopharmaceutical products include plasma-based therapies to treat immune disorders, alpha 1 antitrypsin deficiency and other chronic blood-related conditions; biosurgery products for hemostasis, wound-sealing, and tissue regeneration; and vaccines. Baxter also is a leading manufacturer of manual and automated blood and blood-component separation and collection systems.

Medication Delivery
Baxter is a leading manufacturer of intravenous (IV) solutions and administration sets, premixed drugs and drug reconstitution systems, pre-filled vials and syringes for injectable drugs, electronic infusion pumps, and other products used to deliver fluids and drugs to patients. The company also provides IV nutrition solutions, containers and compounding systems and services; general anesthetic agents and critical care drugs; contract manufacturing services, and drug packaging and formulation technologies.

Renal
Baxter is a leading manufacturer of products for peritoneal dialysis (PD), a home therapy for people with end-stage renal disease, or irreversible kidney failure. These products include a range of PD solutions and related supplies to help patients safely perform solution exchanges, as well as automated PD cyclers that perform solution exchanges for patients overnight while they sleep. Baxter also distributes instruments and disposables, including dialyzers, for hemodialysis, generally conducted in a hospital or clinic.

Because of our commitment to research and development, Baxter’s history is rich with medical firsts, from the first commercially manufactured intravenous (IV) solutions to the first portable kidney dialysis machine, plus many more. Baxter continually pursues breakthrough technologies through research facilities around the world, and our investments reflect that commitment.

 Key Statistics


Email:
Ownership: Public

Web Site: Baxter International, Inc.
Employees:
Symbol: BAX
 





Collaborations

Progenitor Cell Therapy 





 Company News
Baxter International, Inc. (BAX) Submits Application For U.S. FDA Approval Of BAX111, Investigational Recombinant Treatment For Von Willebrand Disease 12/22/2014 11:08:19 AM
Baxter International, Inc. (BAX) To Present At 33rd Annual J.P. Morgan Healthcare Conference 12/19/2014 9:54:23 AM
Baxter International, Inc. (BAX) Fourth Quarter 2014 Financial Results Conference Call 12/18/2014 9:33:26 AM
Baxter International, Inc. (BAX) To Divest Vero Cell Vaccines Platform To Nanotherapeutics 12/15/2014 10:31:38 AM
Baxter International, Inc. (BAX) Announces Filing Of Form 10 Registration Statement In Connection With Planned Spin Off Of Biopharmaceuticals Business 12/11/2014 7:38:03 AM
Baxter International, Inc. (BAX)’s Culture Of Community Engagement And Inclusion Recognized By Leading Organizations 12/9/2014 1:20:53 PM
Baxter International, Inc. (BAX) Submits Application For US FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A 12/2/2014 10:32:25 AM
Pfizer (PFE) Completes Acquisition Of Baxter International, Inc. (BAX)’s Marketed Vaccines 12/1/2014 11:53:08 AM
Baxter International, Inc. (BAX) Submits Application For U.S. FDA Approval Of BAX 855, Extended Half-Life Recombinant FVIII Based On ADVATE For Hemophilia A 12/1/2014 10:37:03 AM
Baxter International, Inc. (BAX) Initiates Voluntary Recall Of One Lot Of Highly Concentrated Potassium Chloride Injection In The U.S. Due To Mislabeled Overpouch 11/21/2014 7:45:45 AM
12345678910...